A 50-year-old man presented for the diagnosis and treatment of a rash on his legs and back for about 1 and 1/2 years. His past medical history was significant for HIV infection which had been treated with Highly Active Anti-Retroviral Therapy (HAART). He stated that his viral counts were undetectable and … Continue reading →
Systemic Lupus Erythematosus (SLE) is a devastating autoimmune disease that can affect nearly every organ system in the body. The skin is no exception, and in fact, may be involved in 70-80% of cases. An equal number of patients may experience abnormal sun or ultraviolet light sensitivity, called photosensitivity. There are … Continue reading →
The answer to the question depends on the extent of training in dermatology and the individual physician’s comfort level in dealing with skin diseases. Currently, the definition of “primary care providers” includes family practitioners, internists, pediatricians, and gynecologists, but may be expanded to include nurse practitioners. The education of U.S. medical … Continue reading →
To better understand the concept of “dysplastic moles,” we must agree on definitions of terms. Dysplastic from dysplasia means abnormal development of tissue. A mole in this context usually refers to a growth in skin that may be pigmented, flesh-colored, flat or raised, hairy or non-hairy.
Actinic keratosis (AK), also known as solar keratosis, are commonly referred to as pre-cancerous skin growths. In fact, they are the most common pre-cancerous growth of humans. Actinic keratoses (plural) are most commonly found on sun exposed areas, namely, the face, lips, bald scalp, and backs of hands and arms.
In 1981, I had the distinct honor and privilege to meet Dr. Frederic E. Mohs at the University of Wisconsin in Madison. He was the surgeon who invented the technique of removing skin cancers with the least amount of normal tissue and the highest possible cure rate. The trick was … Continue reading →
Metastatic malignant melanoma is the deadliest form of skin cancer. Now, for the first time in 13 years, the FDA has approved not one, but two, medicines for metastatic or unresectable malignant melanoma.
Vemurafenib (brand name Zelboraf) is unique among chemotherapeutic agents in two ways: it is a pill taken by … Continue reading →
A lymphoma is a type of cancer that is derived from white blood cells in circulating blood and in lymph nodes called lymphocytes . These cells, known as B-cells and T-cells, play a major role in the body’s immune defense mechanisms against infections and cancer. However, some lymphocytes may themselves … Continue reading →
Basal cell carcinoma (BCC) is the most common malignancy of humans with an estimated 2 million new cases per year in the U.S. It is generally considered that BCC’s are caused, at least in part, by chronic excessive sun exposure over many years’ time. Various surgical techniques, topical chemotherapy creams, … Continue reading →
Dr. Camisa is board certified in dermatology and dermatological immunology, practicing medicine for over 30 years. He is Director of the Phototherapy Department at Riverchase Dermatology and an Affiliate Associate Professor of Dermatology at the University of South Florida in Tampa. He specializes in psoriasis, lichen planus, bullous diseases, connective tissue diseases, cutaneous T-cell lymphoma, and diseases of the mouth and lips. Dr. Camisa is a leading expert in psoriasis, bullous disease, and other complex skin conditions, and patients throughout the country seek his experience. More about Dr. Camisa...